Img/products
0 0 0
 
  • Specimen Validity Test
  • Specimen Collection Cup
  • Integrated Drug Test Cup
  • Hair Follicle Drug Test
  •  

    Alcohol breath analyzer market driving forces relate to greater desire for prevention of accidents of all types, and greater recognition that alcohol is a cause of accidents. Breath analyzer market forecast analysis indicates that the markets are set to grow substantially. The reason is that people are becoming disenchanted with the killing of innocent people by alcohol abusers.

    Work situations are as likely to be unsympathetic with alcohol abuse. The situation is not able to be settled without testing. People that use alcohol are not able to work efficiently.

    In the United States, alcohol plays a part in half the automobile fatalities and nearly half of all industrial accidents. For employers, alcohol abuse accounts for two thirds of all substance abuse complaints and depletes a similar percentage from the health care benefit budgets of American companies.

    In performing a breath alcohol test, it is important to analyze an alveolar or deep lung air sample. If a deep lung sample in not obtained, the sample analyzed could be diluted with breath of a lower alcohol concentration from the upper respiratory tract. This would result in a lower than optimum test result.

    Progress has been made during the past 20 years to reduce the proportion of fatally injured drivers with blood alcohol concentrations (BACs) at or above 0.08 percent. Proportions are lower in all age groups and among drivers of passenger vehicles, tractor-trailers, and motorcycles. There has been a substantial decline among those with very high BACs (at or above 0.15 percent), who often are assumed to be "hard-core" drinking drivers. Progress has stalled in recent years and alcohol-impaired driving is still a major problem.

    There is more recognition that alcohol abuse is a health issue. People are learning how to treat the disease. There is increasing recognition that alcoholism is treatable in hospital based treatment programs. Markets at $27.9 million in 2005 are anticipated to reach $341.7 million by 2011.

    To visit our drug testing products on-line store, CLICK HERE, Please!

     
        Copyright © XALEX 2005 All rights reserved
    Developed by